聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 1 小时 5 分钟 前

Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors

周二, 08/05/2014 - 16:44
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced today that it has appointed Jean-Pierre Sommadossi, PhD, to the company’s Board of Dire...
Biopharmaceuticals, Neurology, Personnel
Alzheon, ALZ-801, Alzheimer’s disease

MELA Sciences Names Michael R. Stewart to Board of Directors

周二, 08/05/2014 - 16:41
Stewart Brings to MELA a Wealth of Dermatological Medical Device Expertise Across All Aspects of the Business IRVINGTON, N.Y., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- MELA Sciences, Inc. (MELA), developer of the MelaFind(R) system, an ...
Devices, Diagnostics, Oncology, Dermatology, Personnel
MELA Sciences, MelaFind, melanoma

Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market

周二, 08/05/2014 - 12:25
QUÉBEC CITY, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) - Aeterna Zentaris Inc. (AEZS) (TSX: AEZ) (the "Company") today announced a strategic co-promotion services agreement with ASCEND Therapeutics® US, LLC, ("ASCEND...
Biopharmaceuticals, Distribution
Aeterna Zentaris, ASCEND Therapeutics, EstroGel, Macrilen

Boston Therapeutics Expands Medical Advisory Board

周二, 08/05/2014 - 12:20
Noted Diabetes Experts Meng H Tan, M.D., Philip Raskin, M.D., and Charles M. Clark, Jr., M.D. to Serve as Medical Advisory Board Members MANCHESTER, NH--(Healthcare Sales & Marketing Network)) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Ther...
Biopharmaceuticals, Personnel
Boston Therapeutics

TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer

周二, 08/05/2014 - 12:15
MENLO PARK, Calif., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- TesoRx Pharma, LLC., a specialty pharmaceutical company focused on rapidly developing and commercializing products in specialty and niche markets, announced today that it has cl...
Biopharmaceuticals, Personnel, Venture Capital
TesoRx Pharma

Caris Molecular Intelligence(TM) Identifies Key Biomarkers of Clinical Benefit and Resistance to Chemotherapy through Multi-Technology Tumor Profiling

周二, 08/05/2014 - 12:11
Peer-Reviewed Case Study from Fox Chase Cancer Center Demonstrates Value of Company's Unique Approach to Precision Medicine to Uncover Critical Treatment Insights IRVING, Texas, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Caris Life Scien...
Diagnostics, Oncology
Caris Life Sciences, Molecular Intelligence, tumor profiling

Akers Appoints New Vice President of International Sales and Marketing to Build International Business

周二, 08/05/2014 - 12:04
THOROFARE, N.J., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Akers Biosciences, Inc. (AKER) (AKR.L) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and testing products, announ...
Diagnostics, Personnel
Akers Biosciences

Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)

周二, 08/05/2014 - 12:01
SAN DIEGO, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa fo...
Biopharmaceuticals, FDA
Genoa Pharmaceuticals, pirfenidone, Esbriet, Idiopathic Pulmonary Fibrosis

RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development

周一, 08/04/2014 - 10:54
CHICAGO--(Healthcare Sales & Marketing Network)-RestorGenex Corporation (RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, announced today the appointment of Mark Weinbe...
Biopharmaceuticals, Personnel
RestorGenex

Hill-Rom Completes Acquisition of Trumpf Medical

周五, 08/01/2014 - 17:00
CHICAGO, Aug. 1, 2014 -- (Healthcare Sales & Marketing Network) -- Hill-Rom Holdings, Inc. (HRC) today announced that it has completed its approximately $250 million purchase of Trumpf Medical, the medical unit of the privately held TRUMPF Group. The tran...
Devices, Surgery, Mergers & Acquisitions
Hill-Rom, Trumpf Medical

FDA Approves Boehringer Ingelheim's Striverdi(R) Respimat(R) (olodaterol) Inhalation Spray for Maintenance Treatment of COPD

周五, 08/01/2014 - 14:25
RIDGEFIELD, Conn., Aug. 1, 2014 -- (Healthcare Sales & Marketing Network) -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved Striverdi® Respimat® (olodaterol) Inhalation Spray 5 mcg as a long-term...
Biopharmaceuticals, FDA
Boehringer Ingelheim, Striverdi Respimat, olodaterol, COPD

European Commission Grants Orphan Drug Designation to Soliris(R) (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

周五, 08/01/2014 - 14:16
CHESHIRE, Conn.--(Healthcare Sales & Marketing Network)--Alexion Pharmaceuticals (ALXN) today announced that the European Commission has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis...
Biopharmaceuticals, Regulatory
Alexion Pharmaceuticals, Soliris, eculizumab, Myasthenia Gravis

MEDICREA’s K-JAWS(R) Obtains FDA Approval for Its Marketing in the United States

周五, 08/01/2014 - 13:49
LYON, France--(Healthcare Sales & Marketing Network)--The MEDICREA Group: (ALMED.PA) (FR0004178572-ALMED), which specializes in the development of innovative surgical technologies for the treatment of spinal pathologies and is listed on Alternext - Paris, ...
Devices, Neurosurgery, Orthopaedic, FDA
MEDICREA, K-JAWS, Cervical Compression Staple

American Shared Hospital Services Announces Proposed 2015 CMS Gamma Knife and Proton Therapy Reimbursement Rates

周四, 07/31/2014 - 15:13
SAN FRANCISCO--(Healthcare Sales & Marketing Network)--AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that the Centers for Medi...
Devices, Oncology, Reimbursement
American Shared Hospital Services, Gamma Knife, proton therapy, radiotherapy

Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel

周四, 07/31/2014 - 15:07
NEW YORK, July 31, 2014 -- (Healthcare Sales & Marketing Network) -- Intra-Cellular Therapies, Inc. (ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the appointment o...
Biopharmaceuticals, Neurology, Personnel
Intra-Cellular Therapies

Smith and Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market

周四, 07/31/2014 - 13:02
LONDON, July 31, 2014 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced its entry into the forefoot market with the launch of the HAT-TRICK™ Lesser Toe Repair System. Co...
Devices, Orthopaedic, Product Launch
Smith & Nephew, HAT-TRICK, Lesser Toe Repair

K2M Continues Momentum with Complex Spine and Minimally Invasive Line Extensions and Regulatory Clearances

周四, 07/31/2014 - 12:53
LEESBURG, Va., July 31, 2014 -- (Healthcare Sales & Marketing Network) -- K2M Group Holdings, Inc. (KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and prop...
Devices, Neurosurgery, Orthopaedic, FDA, Product Launch
K2M, CASPIAN, Occipital Anchor Spinal System, SERENGETI

Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President

周三, 07/30/2014 - 16:03
WESTFORD, Mass., July 30, 2014 -- (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that the Board of Directors ha...
Devices, Dermatology, Personnel
Cynosure, laser

invendo medical Appoints Nachum (Homi) Shamir to the Company's Board of Directors

周三, 07/30/2014 - 16:00
Key addition to board to strengthen invendo's U.S. footprint NEW YORK and KISSING, Germany, July 30, 2014 -- (Healthcare Sales & Marketing Network) -- invendo medical GmbH, manufacturer and distributor of a single use and computer-assisted ("robot...
Devices, Gastroenterology, Personnel
invendo medical, invendoscopy, endoscopy

Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer

周三, 07/30/2014 - 15:56
DEERFIELD, Ill.--(Healthcare Sales & Marketing Network)--Baxter International Inc. (BAX) today announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer Inc. for a t...
Biopharmaceuticals, Acquisitions
Baxter International, Pfizer, NeisVac-C, FSME-IMMUN, vaccine

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong